Concepedia

Author

Ilaria Badagnani

AbbVie (United States)ORCID

Also Known As

I Badagnani, Ilaria Badagnani

30

Publications

554

Citations

11

H-Index

35

Concepts

All Affiliations

AbbVie (United States)University of California, San Francisco
IB

About

Ilaria Badagnani is an author at AbbVie (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

118

2

Engineering

1

1

55

3

Language Studies

1

1

31

4

Natural Sciences

1

1

20

5

Allergy

1

1

12

Ilaria Badagnani

×

10

Publications

450

Citations

10

H-Index

YearCitations

Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants

Ilaria Badagnani, Richard A. Castro, Travis R. Taylor,

Journal of Pharmacology and Experimental Therapeutics

2006

184

Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)

Ilaria Badagnani, Wendy Chan, R A Castro,

The Pharmacogenomics Journal

2005

55

Functional genomics of membrane transporters in human populations

Thomas Urban, Ronnie Sebro, Evan H. Hurowitz,

Genome Research

2005

52

SLC19A1 pharmacogenomics summary

Sook Wah Yee, Li Gong, Ilaria Badagnani,

Pharmacogenetics and Genomics

2010

31

Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

Julie L. Wilsbacher, Min Cheng, Dong Cheng,

Molecular Cancer Therapeutics

2017

31

Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

Shweta Singh, Laura Serwer, Amy DuPage,

Molecular Cancer Therapeutics

2022

26

Molecular Determinants of Specificity for Synthetic Nucleoside Analogs in the Concentrative Nucleoside Transporter, CNT2

Ryan Owen, Ilaria Badagnani, Kathleen M. Giacomini

Journal of Biological Chemistry

2006

25

SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)

Michael L. Curtin, H. Robin Heyman, Richard F. Clark,

Bioorganic & Medicinal Chemistry Letters

2017

20

A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery

Lance Heinle, Vincent Peterkin, Sonia de Morais,

Combinatorial Chemistry & High Throughput Screening

2015

14

Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species

Rhiannon N. Hardwick, Patrick Brassil, Ilaria Badagnani,

Toxicological Sciences

2022

12

Page 1